Personalized Cancer
Personalized cancer medicine aims to tailor cancer treatments to individual patients based on their unique tumor characteristics and genetic makeup. Current research heavily utilizes artificial intelligence, particularly deep learning models like transformers and graph neural networks, to analyze multi-modal data (e.g., MRI, genomic data) for improved diagnosis, treatment prediction (e.g., response to chemotherapy or immunotherapy), and monitoring of tumor dynamics. This approach holds significant promise for improving treatment efficacy, reducing side effects, and ultimately enhancing patient outcomes by moving beyond one-size-fits-all approaches.
Papers
October 31, 2024
August 19, 2024
August 8, 2024
July 27, 2024
March 18, 2024
March 7, 2024
October 2, 2023
November 7, 2021